Crescent Biopharma is illuminating a brighter future for cancer patients with potentially best-in-class therapies to transform solid tumor treatment.
Our pipeline of novel, precision-engineered biologics originated at Paragon Therapeutics, a biotechnology company founded by Fairmount. Crescent is the fifth company launched to advance assets discovered
Crescent will present at the 45th Annual Cowen Health Care Conference 2025, March 3, 2025, in Boston.
